Specific-pathogen-free (SPF) chickens were inoculated with the virus seed of an infectious bursal disease virus (IBDV)-attenuated vaccine, and positive reticuloendotheliosis virus (REV) antibody levels were subsequently detected in the chicken sera, indicating potential REV contamination of the vaccine. After neutralization with IBDV-positive blood serum, the vaccine was inoculated into DF-1 cells for REV isolation and identification. An REV strain, designated IBD-C1605, was identified using an immunofluorescence assay test. Three pairs of primers were employed for the amplification, cloning and sequencing of three overlapping fragments of the IBD-C1605 genome, and the whole-genome sequence of this isolate was obtained after gene assembly. The genome was 8362 base pairs (nt) in length and its homology with the nucleotide sequences of different reference strains varied between 94.2 and 99.2 %. Isolate IBD-C1605 was inoculated into 1-day-old SPF chickens to observe its pathogenicity. Infection with this organism slowed down the weight gain of SPF chickens and caused atrophy of their immune organs, such as the bursa of Fabricius and thymus gland. Furthermore, the chicken antibody levels decreased significantly after Newcastle disease virus and avian influenza virus subtype H9 vaccine immunization. This is the first report on the isolation and identification of REV from attenuated vaccine virus seeds in China, and is also the first study on the pathogenicity of REV from a contaminated vaccine in China. Our findings contribute towards a better understanding of the detrimental effects of vaccine contamination with exogenous viruses such as REV.
INTRODUCTION
Reticuloendotheliosis (RE), an important avian neoplastic and immunosuppressive disease, is caused by reticuloendotheliosis virus (REV). REV can not only infect chickens, but can also infect turkeys, ducks, geese, quail and pheasants (Bohls et al., 2006; Ni & Cui, 2008) . In recent years, a serological survey suggested that Chinese chickens, especially local breeds, showed an increasing positive rate of REV infection (Zhao et al., 2012) . It is worth noting that, both in China and other countries, the misuse of REV-contaminated attenuated virus vaccine is considered to be an important cause of the widespread prevalence of REV (Bagust et al., 1979; Yuasa et al., 1979; Fadly et al., 1996; Diallo et al., 1998; Fadly & Garcia, 2006; Awad et al., 2010; Woźniakowski et al., 2015; Luan et al., 2016) . In China, despite attempts by the government to control REV contamination in attenuated virus vaccines, many cases of vaccine contamination have been reported over recent years (Wang et al., 2010; Wei et al., 2012; Li et al., 2015) .
The REV genome is composed of the gag group-specific antigen (gag), polymerase (pol) and envelope (env) genes, as well as a long terminal repeat (LTR). The env gene, encoding the envelope glycoprotein, can be broken down into two glycoprotein peptide chains, gp90 (surface protein, SU) and gp20 (transmembrane protein). SU is the main immunogenic protein of REV, which can stimulate the organism to produce neutralizing antibodies. The gag gene encodes the core protein, a group-specific structural protein of virus particles. The pol gene encodes enzymes including the protease, reverse transcriptase (RT) and integrase (IN) . IN plays a vital role in REV proliferation and can integrate the provirus genomic cDNA into the chromosome of host cells. isolate and identify REV from the virus seed of a contaminated attenuated virus vaccine in China. We performed wholegenome sequencing analysis of this REV strain and carried out a systematical study on its pathogenicity.
RESULTS

REV isolation and identification
The REV-contaminated IBDV vaccine seed was treated and inoculated into DF-1 cells, which were passaged for two generations. The harvested cell culture medium was inoculated into DF-1 cells, and immunofluorescence assay (IFA) detection was performed using REV mAbs. Specific green fluorescence was clearly observed in positive wells. Fluorescent cells showed clear contours with a stained cytoplasm, and were clearly distinguishable from background staining. The negative control failed to exhibit green fluorescence. The results indicated that an REV strain, named IBD-C1605, was successfully isolated.
Provirus genome sequence and phylogenetic analysis of the REV isolate
We used the genomic DNA of REV cells inoculated with IBD-C1605 isolate as the template, and three pairs of primers designed against the REV genome sequence were adopted for PCR amplification. The targeted fragments were amplified with sizes of 1.8, 3.4 and 3.6 kb, respectively. DNASTAR was employed to assemble the three sequences to obtain the complete provirus nucleotide sequence of isolate IBD-C1605 (GenBank accession number KX278301). The length of the whole-genome sequence of IBD-C1605 was 8362 nt. As for the nucleotide composition, A, G, T and C accounted for 25.40, 26.08, 22.52 and 26 .00 %, respectively.
The CLUSTALW method provided in the DNASTAR software was used for homologous comparison between the provirus whole-genome sequence of isolate IBD-C1605 and the REV reference strains. The results suggested that the sequence homology between the IBD-C1605 whole genome and the reference strains varied between 94.2 and 99.2 % ( Table 1) . The IBD-C1605 strain shared the highest level of nucleotide sequence identity with the GD1210 strain (99.2 %), compared with that shared with the MD-2 strain which was isolated from Marek's disease vaccine (95.7 %) and the FA strain which was isolated from fowlpox virus (FPV) vaccine (94.2 %). Phylogenetic analysis based on whole-genome sequences indicated that IBD-C1605 was closely related to SNV and strain GD1210, all three of which were located on the same branch of the phylogenetic tree (Fig. 1) . The provirus DNA sequence of IBD-C1605 indicated a typical fully replicated retrovirus genomic structure. The length of the LTR was 586 nt, and its homology with reference strains varied between 91.7 and 99.7 %. The length of the gag gene was 1491 nt, and its nucleotide homology with reference strains varied between 94.4 and 96.8 %, its amino acid homology with reference strains varied between 94.0 and 96.1 %. The length of the pol gene was 3582 nt, its nucleotide homology with reference strains varied between 95.4 and 99.9 % and its amino acid homology with reference strains varied between 96.8 and 99.8 %. Finally, the length of the env gene was 1761 nt, its nucleotide homology with reference strains varied between 94.2 and 99.8 % and its amino acid homology with reference strains varied between 91.8 and 99.3 % ( Table 1) .
Pathogenicity of the isolate in specific-pathogenfree chickens Two weeks after the first treatment, the body weights of the specific-pathogen-free (SPF) chickens infected with IBD- (Fig. 2d ) in the chickens. The difference in antibody titre between experimental groups and the control group was highly significant (P<0.001). However, the difference between the two doses was not significant. Furthermore, REV infection resulted in bursa of Fabricius and thymus gland indices that were significantly lower than the control group (P<0.01), indicating atrophy in the these tissues (Fig. 2b) . However, the effect of REV infection on spleen development was not significant (P>0.05).
DISCUSSION
Unlike other viruses, REV and ALV can disperse through contamination of attenuated virus vaccines. There have been many reports on REV (Bagust et al., 1979; Yuasa et al., 1979; Fadly et al., 1996; Diallo et al., 1998; Fadly & Garcia, 2006; Awad et al., 2010) and ALV contamination in different vaccines (Isfort et al., 1992; Davidson & Borenshtainet, 2001; Zavala & Cheng, 2006; Barbosa et al., 2008; Woz´niakowski et al., 2011; Zhao et al., 2014) . Liu and colleagues obtained the REV whole-genome sequence by PCR amplification of an FPV-attenuated virus vaccine, which was the first study that verified REV contamination of an attenuated virus vaccine in China. However, the virus was not successfully isolated in that study (Liu et al., 2009 ). In the same year, an REV strain was successfully isolated and identified from an FPV-attenuated virus vaccine in our laboratory; this was the first report of REV isolation from an attenuated virus vaccine in China (Wang et al., 2010) . Recently, Li and colleagues successfully isolated and identified another REV strain from an Marek's disease virus (MDV)-attenuated virus vaccine, and whole-genome sequencing was performed on that isolate (Li et al., 2015) .
Previous studies have reported that some attenuated vaccines against MDV and FPV in poultry are contaminated by REV. The possible reason is that live-virus vaccines (MDV and FPV) produced by using unauthentic SPF chickens or virus-free cells probably carried cell-free REV. This study confirmed that REV contamination occurred in an IBDV vaccine virus seed, and the IBDV vaccine virus was obtained, continuously cultured on DF-1 cells. There are two causes for REV contamination: one is that the first isolation of IBDV is facilitated by the mixture of IBDV and REV. The other possibility is that the DF-1 cells were contaminated with REV. This study is the first report on the isolation and identification of REV from attenuated vaccine virus seeds in China, and is also the first report to identify the exogenous virus from the vaccine seeds for ALV and CIAV.
In fact, we identified the IBDV seed in the 25-35 passage generations, and the results showed that the live-virus vaccine was contaminated with REV. It is indicated that the contaminated REV can be copied and associated with IBDV replication in the cell, and it did not stop REV replication because of the cellular lesion caused by IBDV. REV Analysis and pathogenicity of RE virus replicated well on DF-1 cells; the REV strain isolated from this study was added to the DF-1 cells that were infected with IBDV and blind passages were performed for six generations. REV was positive for each generation using fluorescent quantitative PCR (Luan et al., 2016 Few studies have investigated the signs and symptoms associated with the pathogenicity of REV-contaminated virus strains. Earlier studies suggested that REV-contaminated vaccine can restrict chicken growth and induce the development of avian tumours (Fadly et al., 1996; Witter et al., 1979) . Witter and colleagues argued that REV-contaminated MDV vaccines can suppress MDV antibody responses (Witter et al., 1979) . In this study, two doses (500 and 2000 TCID 50 ) of the isolate were used to infect 1-day-old SPF chickens. The results indicate that the chicken weights in the treatment groups increased slowly compared with those in the control group. Furthermore, significant atrophy was observed in the development of immune organs, especially for the thymus gland and bursa of Fabricius, which had a serious impact on chicken immune function. Furthermore, REV infection led to a significant decrease in the level of antibody against NDV and AIV-H9 vaccines in immunized chickens compared with the control group (P<0.001). These findings suggest that the misuse of REV-contaminated attenuated vaccine can result in serious consequences.
In conclusion, this study contributes towards our understanding of the detrimental effects caused by REV contamination of vaccines. We suggest that more attention is given to the prevention of REV contamination of vaccines, especially during vaccine virus-seed construction, along with continuous monitoring, to ensure the safety of vaccine virus seeds and related products.
METHODS
Ethics statement. The animal experiments were approved by Shandong Agricultural University Animal Care and Use Committee. Care and maintenance of all chickens were in accordance with the guidelines of the Committee on the Ethics of Animal of Shandong Agricultural University and the biosecurity guidelines.
IBDV suspected to be contaminated with REV. In China, the Ministry of Agriculture requires that all attenuated vaccines for use in chickens undergo screening to detect potential contamination with exogenous viruses, such as avian leukosis virus (ALV), REV and chicken infectious anaemia virus (CIAV). A vaccine virus seed against infectious bursal disease virus (IBDV) was screened for possible contamination with exogenous viruses. Screening was performed 35 and 42 days post-inoculation in SPF chickens using a commercial antibody ELISA kit (IDEXX Corporation). A positive result indicated the presence of REV antibodies and therefore suggested REV contamination.
Isolation and identification of REV from a contaminated vaccine seed. To isolate contaminating virus, 1 ml of the vaccine seed was mixed well with 1 ml of IBDV-specific serum (prepared by the China Institute of Veterinary Drug Control) and incubated at 37 C for 60 min for neutralization, then the mixture was filtered through a 0.22 µm filter. The filtered solution was used to inoculate a monolayer of DF-1 cells (American Type Culture Collection). Viral adsorption was performed in a 5 % CO 2 incubator for 1 h at 37 C. The cells were then further cultured for 7 days after replacing the medium with M199 medium supplemented with 1 % FBS. The cells were passaged for two generations and the supernatant was collected. The cells were fixed following a method reported previously (Qin et al., 2001) and then subjected to an indirect immunofluorescence assay using REV-specific mAb 11B118 (Cui et al., 1988) .
Whole-genome sequencing of the REV isolate. The isolated REV strain was inoculated onto a monolayer of DF-1 cells and allowed to adsorb at 37 C for 2 h. The liquid was then replaced with cell culture maintenance medium containing 1 % FBS, and the REV strain was cultured at 37 C for 7 days. After trypsinization, the cells were centrifuged and collected. The total DNA of the cells was extracted using a cell Table 2 . Primers used in this study to amplify the whole proviral genome of the REV isolate
Primer
Primer sequence 5¢-3¢ Product length (bp) genome DNA extraction kit (Omega Bio-Tek), following the manufacturer's instructions. The extracted DNA was stored at -20 C until required. Based on the published REV genome sequence, we designed and synthesized three pairs of primers to amplify three overlapping fragments (Table 2) . PCR was performed using TaKaRa Ex Taq enzyme reagent kits (TaKaRa Bio), according to the manufacturer's instructions. The amplification products were identified using 1.0 % agarose gel electrophoresis, and the target band was excised from the gel. DNA was then purified using an E.Z.N.A Gel Extraction Kit (Omega Bio-Tek), integrated into a PMD-18T vector and transformed into Escherichia colicompetent DH5a cells. The plasmids of all single colonies were extracted using a Plasmid Mini Kit (Omega Bio-Tek), followed by identification by restriction analysis. Positive clones were sequenced (Sangon Biotech).
Sequence alignment and phylogenetic analysis. The nucleotide sequences of the three amplified fragments were assembled to obtain the whole-genome sequence of the provirus isolate using DNASTAR software (DNASTAR). Whole-and partial-genome sequence alignments were performed for the isolate and the representative REV reference sequences obtained from the GenBank database. Nucleotide and amino acid sequence alignments were performed using the CLUSTAL application in the MegAlign program of the DNASTAR, version 7.01, software suite (DNASTAR). The CLUSTALW computational tool was used for sequence alignments during phylogenetic analysis. The accession numbers and the source of the reference strains are listed in Table 3 .
The pathogenicity of the isolate. Seventy-five 1-day-old SPF chickens, provided by SPAFAS (a joint venture with Charles River Laboratory, Wilmington, MA, USA), were randomly classified into three groups, and raised in SPF animal isolation rooms with a filtered-air positivepressure ventilation system. The chickens in one group were injected intraperitoneally with 500 TCID 50 of REV isolates, another group were treated with 2000 TCID 50 of REV isolates and the third group were inoculated with an equal volume of PBS as a blank control. Seven days after the first treatment, inactivated vaccines for NDV (Qilu Animal Health Products, manufacturer's recommended dose: 0.2 ml, Strain LaSota) and AIV-H9 (Qilu Animal Health Products, manufacturer's recommended dose: 0.3 ml, Strain LG1) were administered by immunizing all of the SPF chickens. Sera were then collected from each chicken at 3, 4, 5, 6 or 7 weeks of age. The haemagglutination inhibition test was carried out to measure the efficiency of antibodies against NDV and AIV-H9, and the weight of the chickens was recorded. At 7 weeks of age, six chickens were randomly selected from each group and weighed. The chickens were then euthanized, and their immune organs such as the bursa of Fabricius, thymus gland and spleen were weighed. The immune organ indices (bursa of Fabricius/body weight, thymus gland/body weight, and spleen/body weight) were calculated according to previously reported methods .
Statistical analysis. All statistical analyses were performed using SPSS statistical software package for WINDOWS, version 17.0 (SPSS). Statistical comparisons were made using Student's t-test.
